drugset / Trial / NCT06002490
A Study to Evaluate P1101 in Japanese PV Patients
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 3 single arm study to investigate efficacy and safety of P1101's rapid titration for adult Japanese patients with PV.
Timeline
- Start
- 2023-10-17
- Primary completion
- 2024-07-26
- Completion
- 2024-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropeginterferon alfa-2b | Protein / enzyme biologic | 500 ug | Subcutaneous |
| Background | Low-dose aspirin | Unknown | 75 mg | — |
| Background | Low-dose aspirin | Unknown | 150 mg | — |